Related Experiment Video
Updated: Aug 26, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Epigenetic factors in breast cancer therapy
Runjhun Mathur1,2, Niraj Kumar Jha1,3,4, Gaurav Saini5
1Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India.
Abstract:
Epigenetic modifications are inherited differences in cellular phenotypes, such as cell gene expression alterations, that occur during somatic cell divisions (also, in rare circumstances, in germ line transmission), but no alterations to the DNA sequence are involved. Histone alterations, polycomb/trithorax associated proteins, short non-coding or short RNAs, long non-coding RNAs (lncRNAs), & DNA methylation are just a few biological processes involved in epigenetic events. These various modifications are intricately linked. The transcriptional potential of genes is closely conditioned by epigenetic control, which is crucial in normal growth and development. Epigenetic mechanisms transmit genomic adaptation to an environment, resulting in a specific phenotype. The purpose of this systematic review is to glance at the roles of Estrogen signalling, polycomb/trithorax associated proteins, DNA methylation in breast cancer progression, as well as epigenetic mechanisms in breast cancer therapy, with an emphasis on functionality, regulatory factors, therapeutic value, and future challenges.
Insights
Epigenetic modifications regulate gene expression without altering DNA sequence. This review explores their role in breast cancer progression and therapy, focusing on estrogen signaling and DNA methylation.
Area of Science:
- Epigenetics and Molecular Biology
- Cancer Research
Background:
- Epigenetic modifications are heritable changes in gene expression, not DNA sequence.
- Key epigenetic mechanisms include histone alterations, DNA methylation, and non-coding RNAs.
- These modifications are vital for normal development and environmental adaptation.
Purpose of the Study:
- To review the role of epigenetic mechanisms in breast cancer progression.
- To examine the influence of estrogen signaling, polycomb/trithorax proteins, and DNA methylation in breast cancer.
- To assess epigenetic strategies in breast cancer therapy, including functionality, regulation, and therapeutic potential.
Main Methods:
- Systematic review of existing literature.
- Analysis of epigenetic regulatory factors in breast cancer.
- Evaluation of therapeutic implications of epigenetic modifications.
Main Results:
- Estrogen signaling, polycomb/trithorax proteins, and DNA methylation are implicated in breast cancer progression.
- Epigenetic mechanisms offer potential therapeutic targets for breast cancer treatment.
- Understanding epigenetic regulation is crucial for developing effective cancer therapies.
Conclusions:
- Epigenetic modifications play a significant role in breast cancer development and progression.
- Targeting epigenetic pathways presents a promising avenue for novel breast cancer therapies.
- Further research is needed to overcome challenges and optimize epigenetic therapies for breast cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Epigenetic Regulation
X-chromosome...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

